Company Strategy Merck Versus Pfizer Essay

Tags: european union intellectual property drugs merck budget pfizer advertising marketing diseases fda china india profitability

Open, View, and/or
Download this Document

Total Length: 697 words ( 2 double-spaced pages)

Total Sources: 1

Page 1 of 2

Q1.Why has the attractiveness of the pharmaceutical industry declined so much since the 1980’s? What are the implications of those changes in industry structure for firm strategy?

Despite the tremendous profits garnered by large pharmaceutical companies for so-called blockbuster drugs, pharmaceutical companies must make huge investments in R&D to produce profitable medications. The vast majority of drugs which are developed and tested never go to market. Additionally, once companies produce valuable drugs, they have a limited window on which to capitalize upon a drug’s profitability before its compounds can be sold in the form of a much cheaper generic. The FDA shortened the patient life of drugs from 11-12 years from 17-20, thus vastly reducing the financial ability of companies to cash in on valuable non-generics (Collis & Smith, 2007, p.5).

The industry structure also changed significantly, as more and more companies began to enter into the fray of developing new drugs. With the expansion of the European Union, approval was facilitated for new drugs across all member nations, thus empowering European companies with the ability to make greater profits (Collis & Smith, 2007, p.6). The developing nations of China and India became more competitive, as China had access to more raw chemical materials to produce drugs and India began to graduate more highly trained specialists in the field of chemical engineering (Collis & Smith, 2007, p.6). Greater competition means that companies must price their products more competitively.

Stuck Writing Your "Company Strategy Merck Versus Pfizer" Essay?

View All Our Example Company Strategy Merck Versus Pfizer Essay

Have A Custom Example Essay Written



One of Porter’s Five Forces is the ability of firms to enter the market. This enabled more international firms to enter the market for developing pharmaceuticals. They had lower costs regarding gaining regulatory approval, cheaper raw materials, and expanded access to the necessary intellectual property to develop new drugs. The power of buyers also increased, as national health services (as existed in the United Kingdom) began to favor less costly drugs like generics or looked less favorably upon newer, more expensive drugs. Similarly, health insurance companies in the United States began to favor less costly alternatives. Particularly in the face of a lack of new drugs that offer a genuinely new approach to treating disease, profit-making became much more limited.

Q2. How do you evaluate Merck and Pfizer’s strategies in the light of changing industry structure?

Merck had historically focused on the development of blockbuster drugs for a variety of diseases. It capitalized upon its high approval….....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


Reference

Collis, D. & Smith, T. (2007). Strategy in the twenty-first century pharmaceutical industry: Merck versus Pfizer. Cambridge, MA: Harvard Business School.

sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Company Strategy Merck Versus Pfizer" (2018, October 07) Retrieved April 18, 2024, from
https://www.aceyourpaper.com/essays/company-strategy-merck-versus-pfizer-essay

Latest MLA Format (8th edition)

Copy Reference
"Company Strategy Merck Versus Pfizer" 07 October 2018. Web.18 April. 2024. <
https://www.aceyourpaper.com/essays/company-strategy-merck-versus-pfizer-essay>

Latest Chicago Format (16th edition)

Copy Reference
"Company Strategy Merck Versus Pfizer", 07 October 2018, Accessed.18 April. 2024,
https://www.aceyourpaper.com/essays/company-strategy-merck-versus-pfizer-essay
   

Open, View, and/or
Download this Document
order custom essay example